Asthma Clinical Trials

Find Asthma Clinical Trials Near You

Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is testing a new way to help adults with asthma get follow up care after an emergency room (ER) visit for an asthma attack. Many people who come to the ER for asthma never see an asthma specialist afterward, even though specialists can offer treatments such as advanced inhalers or biologic medicines that may prevent future attacks. The study will compare two approaches. One group will receive a telehealth appointment with an asthma specialist that is scheduled for them before they leave the ER. The other group will receive the usual care, which typically includes a standard referral but no scheduled appointment. All participants will be offered a prescription for standard controller medication at discharge. The main question the study aims to answer is whether arranging a telehealth visit directly from the ER increases the number of patients who complete a follow up appointment with an asthma specialist within three months. The study will also look at whether this approach improves asthma control, reduces repeat ER visits, and helps patients better understand and use their asthma medications. This research may help identify a practical way to improve access to asthma specialists and reduce the burden of asthma for patients who frequently rely on emergency care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years

• Asthma diagnosis ≥1 year

• Seen in ER for asthma exacerbation

• Persistent asthma on controller therapy

• ≥1 asthma exacerbation in prior year

Locations
United States
Florida
Tampa General Hospital Emergency Room
RECRUITING
Tampa
Contact Information
Primary
Amanda McNamara, BA, LPN
Alett1@usf.edu
813-396-2729
Time Frame
Start Date: 2026-07-19
Estimated Completion Date: 2027-08
Participants
Target number of participants: 40
Treatments
Experimental: Intervention Arm
Participants will receive two components:~1. Emergency Room (ER) staff will directly contact the asthma specialist's scheduling team to arrange a follow-up appointment within 1-3 weeks.~2. The follow-up appointment will be conducted via telehealth (including phone calls) to assess follow-up care and asthma control of all participants.~Both Arms:~• All participants will be offered a prescription for twice-daily ICS/LABA (fluticasone/salmeterol) controller therapy at ER discharge after signing informed consent. These medications are standard of care for asthma.~Asthma-related surveys and study-specific questionnaires, medication side effects (open-ended) and follow-up care questions will be administered during the ER visit and again at the 3-month follow-up phone call.
No_intervention: Usual Care Arm
Participants will receive an EMR-based referral to an outpatient allergy clinic, with the option of a telehealth or in-person visit at their discretion. This referral will be offered during the 3-month follow-up phone call to ensure clinical equipoise.~Both Arms:~• All participants will be offered a prescription for twice-daily ICS/LABA (fluticasone/salmeterol) controller therapy at ER discharge after signing informed consent. These medications are standard of care for asthma.~Asthma-related surveys and study-specific questionnaires, medication side effects (open-ended) and follow-up care questions will be administered during the ER visit and again at the 3-month follow-up phone call.
Related Therapeutic Areas
Sponsors
Collaborators: University of South Florida, Tampa General Hospital, Sanofi
Leads: Juan Carlos Cardet

This content was sourced from clinicaltrials.gov